How the Inflation Reduction Act of 2022 Impacts Medicare Part D and Employer-Sponsored Coverage
The Inflation Reduction Act of 2022 introduces significant changes to Medicare Part D that could impact your company’s prescription drug coverage. From new out-of-pocket caps to insulin pricing, these updates may affect your plan’s status as “creditable” coverage.
ACA Affordability Safe Harbor Adjustment for 2025
The IRS has announced an increase in the ACA affordability threshold to 9.02% for 2025. This change may require employers to adjust health coverage contributions to remain compliant with ACA regulations and avoid penalties. Learn more about how these updates impact your responsibilities as an employer.
What do Employers Need to Know about RxDC Reporting?
Employers are now required to submit annual RxDC reports detailing prescription drug and healthcare spending under the Consolidated Appropriations Act. This blog covers the key reporting requirements, deadlines, and steps to ensure compliance with federal regulations.